Stopping Cancer Before It Starts in Lynch Syndrome
At the AACR Annual Meeting 2026, researchers discussed the use of vaccines and aspirin to prevent cancer in people with Lynch syndrome.
The post Stopping Cancer Before It Starts in Lynch Syndrome appeared first on American Association for Cancer Research (AACR).
AACR D3: The ‘Global One-stop Conference’ for Drug Discovery and Development
The inaugural AACR Drug Discovery and Development (AACR D3) meeting will convene experts to reshape the future of oncology therapeutics.
The post AACR D3: The ‘Global One-stop Conference’ for Drug Discovery and Development appeared first on American Association for Cancer Research (AACR).
Editors’ Picks, May 2026: Insights Into CAR T Therapy, Neuron-Tumor Crosstalk in Pancreatic Cancer, and More
In May, AACR’s journals editors highlighted studies on CD28’s impact on CAR T-cell activity, the relationship between neurons and pancreatic cancer, and more.
The post Editors’ Picks, May 2026: Insights Into CAR T Therapy, Neuron-Tumor Crosstalk in Pancreatic Cancer, and More appeared first on American Association for Cancer Research (AACR).
From Pixels to Patients: How AACR on Campus Is Transforming Cancer Research in Colombia
In February, AACR partnered with the Instituto Nacional de Cancerología and Fundación Valle del Lili for two AACR on Campus Colombia events.
The post From Pixels to Patients: How AACR on Campus Is Transforming Cancer Research in Colombia appeared first on American Association for Cancer Research (AACR).
Bloodlines Series: CAR T-cell Therapy Shows Promise for Smoldering Myeloma
An immunotherapy typically used in advanced stages of multiple myeloma may be effective against an early form of the disease known as smoldering myeloma—offering a potential new option for a disease that, until recently, had no approved treatments. The treatment, ciltacabtagene autoleucel (Carvykti), is a chimeric antigen receptor (CAR) T-cell therapy, a type of immunotherapy […]
The post Bloodlines Series: CAR T-cell Therapy Shows Promise for Smoldering Myeloma appeared first on American Association for Cancer Research (AACR).
From the Bench, AACR Annual Meeting 2026: Innovative Tools Uncover New Insights Into Cancer
The latest edition of our “From the Bench” series examines creative research approaches presented at the AACR Annual Meeting 2026 enabling new insights into cancer.
The post From the Bench, AACR Annual Meeting 2026: Innovative Tools Uncover New Insights Into Cancer appeared first on American Association for Cancer Research (AACR).
From War to Recovery: How Global Collaboration Sustains Cancer Research and Care in Ukraine
Amid disruption in Ukraine, international partnerships are preserving oncology progress—and building the foundation for long-term recovery.
The post From War to Recovery: How Global Collaboration Sustains Cancer Research and Care in Ukraine appeared first on American Association for Cancer Research (AACR).
From Bench to Bedside: How a Discovery About Menin Led to New Treatments for Acute Myeloid Leukemia
An AACR grant to study menin’s structure gave researchers the 3D map they needed to produce new treatments for acute myeloid leukemia.
The post From Bench to Bedside: How a Discovery About Menin Led to New Treatments for Acute Myeloid Leukemia appeared first on American Association for Cancer Research (AACR).
Anthony Letai, MD, PhD, FAACR, Lays Out NCI’s Priorities at the AACR Annual Meeting 2026
At the AACR Annual Meeting 2026, National Cancer Institute Director Anthony Letai offered insights into what NCI considers to be priorities.
The post Anthony Letai, MD, PhD, FAACR, Lays Out NCI’s Priorities at the AACR Annual Meeting 2026 appeared first on American Association for Cancer Research (AACR).
AI Empowers Patients to Navigate Cancer Care
An AACR Patient Advocate Forum assembled a panel of experts to discuss how AI tools can help advance cancer research and educate patients.
The post AI Empowers Patients to Navigate Cancer Care appeared first on American Association for Cancer Research (AACR).